The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00894946 |
Recruitment Status
: Unknown
Verified May 2009 by University of Auckland, New Zealand.
Recruitment status was: Recruiting
First Posted
: May 7, 2009
Last Update Posted
: May 7, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Endometriosis In Vitro Fertilization Implantation Failure | Procedure: Lipiodol + IVF Procedure: IVF | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 350 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | The in Vitro Fertilisation - Lipiodol Uterine Bathing Effect Study |
Study Start Date : | May 2009 |
Estimated Primary Completion Date : | May 2014 |
Estimated Study Completion Date : | May 2014 |

Arm | Intervention/treatment |
---|---|
Experimental: Recurrent IVF implantation failure |
Procedure: Lipiodol + IVF
IVF preceded by lipiodol
Procedure: IVF
IVF alone
|
Experimental: Endometriosis |
Procedure: Lipiodol + IVF
IVF preceded by lipiodol
Procedure: IVF
IVF alone
|
- Live birth [ Time Frame: 12 months post-randomization ]
- Clinical pregnancy [ Time Frame: 3 months post-randomization ]
- Adverse events [ Time Frame: 3 & 12 months post-randomization ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 39 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 12 or more months infertility
- Age 18 to 39
- Endometriosis or recurrent IVF implantation failure
- Patent fallopian tubes
Exclusion Criteria:
- Iodine allergy
- Blocked fallopian tube or tubes

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00894946
Contact: Neil Johnson, MD | +64 274360172 | n.johnson@auckland.ac.nz | |
Contact: Shelley Reilly, MRANZCOG | sreilly@adhb.govt.nz |
New Zealand | |
University of Auckland | Recruiting |
Auckland, New Zealand | |
Contact: Neil Johnson, MD +64 274 360172 n.johnson@auckland.ac.nz | |
Principal Investigator: Neil P Johnson, MD | |
Sub-Investigator: Shelley J Reilly, MRANZCOG | |
Sub-Investigator: Cindy M Farquhar, MD | |
Sub-Investigator: Alistair Stewart |
Principal Investigator: | Neil Johnson, MD | University of Auckland, New Zealand |
Responsible Party: | Associate Professor Neil Johnson, University of Auckland |
ClinicalTrials.gov Identifier: | NCT00894946 History of Changes |
Other Study ID Numbers: |
IVF-LUBE |
First Posted: | May 7, 2009 Key Record Dates |
Last Update Posted: | May 7, 2009 |
Last Verified: | May 2009 |
Keywords provided by University of Auckland, New Zealand:
recurrent IVF implantation failure |
Additional relevant MeSH terms:
Endometriosis Genital Diseases, Female Ethiodized Oil Antineoplastic Agents |